Stem Cell Therapy in India — Regenerative Medicine at Leading Hospitals
Stem cell therapy in India is regulated and approved by the Indian Council of Medical Research (ICMR), with partner hospitals offering autologous (patient’s owncells), allogeneic (donor cells), and cord blood therapies. India’s regenerative medicine centres comply with GMP standards for stem cell processing. Conditions treated with ICMR-approved protocols include muscular dystrophy, cerebral palsy, spinal cord injury, autism spectrum disorder, motor neurone disease, orthopaedic cartilage repair, and autoimmune conditions. Bone marrow transplantation for blood cancers is also available at dedicated haemato-oncology centres.
Why India? Key Points
- ICMR-approved stem cell protocols — evidence-based, not experimental
- Autologous processing in GMP-certified labs
- Stem cell therapy 40–60% less than UAE or Germany
- Full genetic and laboratory assessment pre-therapy
- Post-therapy rehabilitation and monitoring included
- Bone marrow transplant for blood cancers available
Sub-Treatments Covered
- Autologous Stem Cell Therapy
- Allogeneic Stem Cell Transplant
- Bone Marrow Transplant
- Stem Cells for Neurological Conditions
- Stem Cells for Cartilage Repair
- PRP (Platelet-Rich Plasma) Therapy
- Hydrocephalus Treatment
🏥 Best Hospitals for Stem Cell Therapy Treatment in India
Fortis Memorial Research Institute is a JCI-accredited quaternary-care hospital in Gurgaon, consistently ranked among India's top 5 smart hospitals, handling the country's most complex referral cases in cardiac, neurology, and oncology.
Medanta — The Medicity in Gurgaon is India's highest-ranked private hospital, treating over 20,000 international patients annually from 130 countries, with 1,391 beds and 40 operating theatres across a 43-acre campus.
Fortis Escorts Heart Institute in New Delhi is one of Asia's highest-volume dedicated cardiac hospitals, performing over 170,000 heart surgeries since 1988 and home to India's first robotic cardiac surgery programme.
👨⚕️ Top Doctors for Stem Cell Therapy in India
Frequently Asked Questions
ICMR-approved conditions: blood cancers (BMT), muscular dystrophy, cerebral palsy, spinal cord injury, autism, orthopaedic cartilage damage, autoimmune conditions.
Autologous therapy: $5,000–$10,000. Bone marrow transplant: $18,000–$30,000. PRP therapy: $500–$1,500 per session.
Safe at ICMR-approved hospitals using regulated protocols. We only work with hospitals complying with ICMR and GMP standards.
Autologous uses patient’s own cells — no rejection risk. Allogeneic uses donor cells — used for blood cancers where patient’s own marrow is diseased.
Varies by condition. Some patients need single infusion; others need 3–6 sessions over months. Personalised protocol based on condition and response.
